Trial intelligence / Profile preview

Safety and Immunogenicity of 2009-2010 Influenza Vaccine

NCT00918268Phase 2Completed

Sponsor
Novartis
Start
Jun 2009
Primary completion
Jul 2009
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of agriflu in influenza, sponsored by Novartis. Started Jun 2009; status: completed.

02

Drugs

agriflu
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00918268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00918268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call